Health-related quality of life in patients with locally advanced or metastatic breast cancer treated with eribulin mesylate or capecitabine in an open-label randomized phase 3 trial

Title
Health-related quality of life in patients with locally advanced or metastatic breast cancer treated with eribulin mesylate or capecitabine in an open-label randomized phase 3 trial
Authors
Keywords
Breast cancer, Eribulin, Quality of life, Minimally important difference, Side effects
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 154, Issue 3, Pages 509-520
Publisher
Springer Nature
Online
2015-11-14
DOI
10.1007/s10549-015-3633-7

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started